Free Trial
ASX:NAN

Nanosonics (NAN) Stock Price, News & Analysis

Nanosonics logo

About Nanosonics Stock (ASX:NAN)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
740,249 shs
Average Volume
N/A
Market Capitalization
$1.02 billion
P/E Ratio
78.25
Dividend Yield
8.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Remove Ads
Receive NAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanosonics and its competitors with MarketBeat's FREE daily newsletter.

NAN Stock News Headlines

Wilsons Keeps Their Buy Rating on Nanosonics Limited (NNCSF)
Nanosonics Limited (NNCSF) Gets a Buy from Morgans
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
ASX Growth Stocks With High Insider Ownership To Watch
See More Headlines

NAN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanosonics investors own include Nanosonics (NNCSF), Calix (CXL), Insignia Financial (IFL), Bubs Australia (BUB), EML Payments (EML), Isracann Biosciences (ISCNF) and Audentes Therapeutics (BOLD).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Financial Services
Current Symbol
ASX:NAN
CIK
N/A
Fax
N/A
Employees
482
Year Founded
N/A

Profitability

Trailing P/E Ratio
78.25
Forward P/E Ratio
N/A
P/E Growth
2.74
Net Income
$12.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.01 million
Price / Cash Flow
25.90
Book Value
A$0.60 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.02 billion
Optionable
Not Optionable
Beta
1.55
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (ASX:NAN) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners